A
ALLO//CIK 0001737287
Allogene Therapeutics, Inc.
Market Data
$2.48−$0.17 (−6.42%)
ALLO · Last trade
Prev Close
$2.65
Range (30d)
$2.07 – $2.71
Recent Filings
- 10-K11.9 MBAllogene Therapeutics, Inc.Mar 12, 4:11 PM ET·0001628280-26-017242
- 8-K229.7 KBAllogene Therapeutics, Inc.Mar 12, 4:07 PM ET·0001628280-26-017230
- 10-Q7.5 MBAllogene Therapeutics, Inc.Nov 6, 4:30 PM ET·0001628280-25-050230
- 8-K209.8 KBAllogene Therapeutics, Inc.Nov 6, 4:28 PM ET·0001628280-25-050227
- 8-K141.7 KBAllogene Therapeutics, Inc.Oct 10, 5:31 PM ET·0001628280-25-044828
- 10-Q7.4 MBAllogene Therapeutics, Inc.Aug 13, 4:14 PM ET·0001737287-25-000088
- 8-K210.5 KBAllogene Therapeutics, Inc.Aug 13, 4:08 PM ET·0001737287-25-000087
- 8-K140.0 KBAllogene Therapeutics, Inc.Aug 1, 9:24 AM ET·0001193125-25-171091
- 8-K154.7 KBAllogene Therapeutics, Inc.Jun 23, 4:28 PM ET·0001737287-25-000070
- 10-Q7.5 MBAllogene Therapeutics, Inc.May 13, 4:07 PM ET·0001737287-25-000064
Insiders
10- Amado RafaelEVP of R&D and CMO
- Barrett Elizabeth A.Director
- Belldegrun ArieDirector
- Beneski Benjamin MachinasSVP, Chief Technical Officer
- Bhavnagri VeerGeneral Counsel
- BONDERMAN DAVIDDirector, 10% Owner
- Chang David DDirector, President and CEO
- CHEN YINLIN JACKSVP, Finance
- COULTER JAMES G10% Owner
- DEYOUNG JOHN A.Director
Tickers
Addresses
business
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080
mailing
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080